A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Add-on Study of MLR 1023 in Adults With Uncontrolled Type 2 Diabetes on Metformin Therapy
Phase of Trial: Phase II
Latest Information Update: 03 Oct 2017
At a glance
- Drugs Tolimidone (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Melior Pharmaceuticals, Inc.
- 03 Oct 2017 According to a Melior Pharmaceuticals media release, the first patient has been randomized and dosed in this trial.
- 19 Sep 2017 Status changed from not yet recruiting to recruiting.
- 08 Sep 2017 Status changed from planning to not yet recruiting.